Keiko Kanamori

Dr. Keiko Kanamori


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2004 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
KKKeiko Kanamori
Keiko Kanamori
BRBrian D. Ross
Brian D. Ross
The basal concentration of glutamine in the extracellular fluid, [GLNECF], was determined to be 385 ± 16 μmin the cortico‐striatal region of awake rats. Thisin vivoconcentration was determined by measuring glutamine concentrations in dialysates collected at several flow rates (0.2–4 μL/min), and extrapolating to the concentration at zero flow‐rate. Dialysate glutamine concentrations in the somatosensory cortex, hippocampus and thalamus showed no statistically significant difference. In these brain regions, [GLNECF] was elevated 1.5‐ to 1.8‐fold upon perfusion of 50–250 mmα‐(methylamino)isobutyrate (MeAIB), a competitive inhibitor of glutamine uptake by system A amino acid transporter. The results show, for the first time, that MeAIB causes elevation of brain GLNECFin vivo. The MeAIB‐induced elevation of [GLNECF] provides additional support for the current view that system A GLN transporter (Gln T/SAT 1) is the major pathway for the uptake of GLNECFby neurons, while GLN release from glia is mainly mediated by a system N transporter (SN1) which is not inhibitable by MeAIB. The steady‐state GLNECFconcentration and the effectiveness of MeAIB in inhibiting neuronal GLN uptakein vivo, reported in this study, will be useful, when combined with the knownin vitrokinetic properties of the GLN transporters, for study of GLN transport in the intact brain.

1 January 2011 in Brain Research
Verified
Journal Article
Closed access
KKKeiko Kanamori
Keiko Kanamori
BRBrian D. Ross
Brian D. Ross

10 June 2005 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
KKKeiko Kanamori
Keiko Kanamori
BRBrian D. Ross
Brian D. Ross
Release of glial glutamine (GLN) to the extracellular fluid (ECF), mainly mediated by the bidirectional system N transporter SN1, was studiedin vivoin hyperammonemic rat brain, using15N‐nuclear magnetic resonance (NMR) to monitor intracellular [5‐15N]GLN and microdialysis/gradient1H‐15N heteronuclear single‐quantum correlation NMR to analyse extracellular [5‐15N]GLN. GLNECFwas elevated to 2.4 ± 0.2 mmafter 4.5 h of intravenous ammonium acetate infusion. The [GLNi]/[GLNECF] ratio (i = intracellular) was 9.6 ± 0.9, compared with 17–20 in normal brain. GLNECFthen decreased substantially att = 4.9 ± 0.1 h. Comparison of the time‐courses of intra‐ and extra‐cellular [5‐15N]GLN strongly suggested that the observed decrease reflects partial suppression of glial GLN release to ECF. Suppression also followed elevation of GLNECFto 1.9 mm, resulting in a [GLN]i/[GLNECF] ratio of 8.4, upon perfusion ofα‐(methylamino)isobutyrate which inhibits neuronal uptake of GLNECFmediated by sodium‐coupled amino acid transporter (SAT). The results provide first evidence for bidirectional operation of SN1in vivo, and clarify the effect of transmembrane GLN gradient on glial GLN release at physiological Na+gradient. Implications of the results for SN1 as an additional regulatory site in the glutamine/glutamate cycle and utility of this approach for examining the role of GLN in an experimental model of fulminant hepatic failure are discussed.

8 August 2006 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
KKKeiko Kanamori
Keiko Kanamori
BRBrian D. Ross
Brian D. Ross
Kinetics of glial glutamine (GLN) transport to the extracellular fluid (ECF) and the mechanism of GLNECFtransport into the neuron – crucial pathways in the glutamine–glutamate cycle – were studiedin vivoin mildly hyperammonemic rat brain, by NMR and microdialysis to monitor intra‐ and extracellular GLN. The minimum rate of glial GLN efflux, determined from the rate of GLNECFincrease during perfusion of α‐(methylamino)isobutyrate (MeAIB), which inhibits neuronal GLNECFuptake by sodium‐coupled amino‐acid transporter (SAT), was 2.88 ± 0.22 μmol/g/h at steady‐state brain [GLN] of 8.5 ± 0.8 μmol/g. Our previous study showed that the rate of glutamine synthesis under identical experimental conditions was 3.3 ± 0.3 μmol/g/h. At steady‐state glial [GLN], this is equal to its efflux rate to the ECF. Comparison of the two rates suggests that SAT mediates at least 87 ± 8% (= 2.88/3.3 × 100%) of neuronal GLNECFuptake. While MeAIB induced > 2‐fold elevation of GLNECF, no sustained elevation was observed during perfusion of the selective inhibitor of LAT, 2‐amino‐bicyclo[1,1,2]heptane‐2‐carboxylic acid (BCH), or ofd‐threonine, a putative selective inhibitor of ASCT2‐mediated GLN uptake. The results strongly suggest that SAT is the predominant mediator of neuronal GLNECFuptake in adult rat brainin vivo.


3 October 2020 in Brain Sciences
Verified
Journal Article
Open access
PDF file
KNKhoa Nguyen
Khoa Nguyen
KKKeiko Kanamori
Keiko Kanamori
CSChang Sung Shin
Chang Sung Shin
AHAbdul Hamid
Abdul Hamid
Kabirullah LutfyKabirullah Lutfy
Kabirullah Lutfy
We assessed if there were any sex-related differences in the ability of nicotine to increase plasma corticosterone secretion after single or repeated nicotine administration. For single-dose studies, male and female mice were habituated to the test room for 1 h and injected with saline or nicotine (0.25 or 1 mg/kg, subcutaneously (s.c.)). In repeated-dosing studies, mice were injected with saline or nicotine (1 mg/kg, s.c.) once daily for six days, and, on day 7, received nicotine (1 mg/kg, s.c.). Mice were then euthanized 15 min later, and trunk blood was collected for the measurement of corticosterone, nicotine, and cotinine. Our results showed that saline or nicotine each significantly increased plasma corticosterone levels in both males and females, with a greater response in female mice. Plasma corticosterone levels were increased in male but not female mice after being treated repeatedly compared to single nicotine administration. The level of cotinine, a biomarker of nicotine use, was significantly higher in female than in male mice. Taken together, these novel findings suggest that female mice respond to nicotine and the stress of handling more than male mice and provide for the first-time quantitative data on male–female differences in nicotine-induced elevations of corticosterone and cotinine plasma levels.